{"cik":1100397,"taxonomy":"us-gaap","tag":"CurrentIncomeTaxExpenseBenefit","label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","entityName":"AYALA PHARMACEUTICALS, INC.","units":{"USD":[{"start":"2022-01-01","end":"2022-12-31","val":584000,"accn":"0001493152-24-014822","fy":2023,"fp":"FY","form":"10-K","filed":"2024-04-16","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":-3912000,"accn":"0001493152-24-014822","fy":2023,"fp":"FY","form":"10-K","filed":"2024-04-16","frame":"CY2023"}]}}